Katherine Z Isoardi1,2,3, Geoffrey K Isbister4,5. 1. Clinical Toxicology Unit, Princess Alexandra Hospital, Ipswich Rd, Woolloongabba Q 4102, Brisbane, QLD, Australia. katherine.isoardi@health.qld.gov.au. 2. Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia. katherine.isoardi@health.qld.gov.au. 3. Clinical Toxicology Research Group, University of Newcastle, Newcastle, NSW, Australia. katherine.isoardi@health.qld.gov.au. 4. Clinical Toxicology Research Group, University of Newcastle, Newcastle, NSW, Australia. 5. Department of Clinical Toxicology, Calvary Mater Newcastle, Newcastle, NSW, Australia.
Authors: Lena E Friberg; Geoffrey K Isbister; L Peter Hackett; Stephen B Duffull Journal: J Pharmacokinet Pharmacodyn Date: 2005-08 Impact factor: 2.745